What is Qilu Pharmaceutical's Ertapenem?
Qilu Pharmaceutical manufactures ertapenem, an injectable carbapenem-class antibiotic used to treat certain serious bacterial infections. It is a broad-spectrum antibiotic effective against many Gram-positive and Gram-negative bacteria [1]. Ertapenem is indicated for moderate to severe intra-abdominal infections, skin and skin structure infections, community-acquired pneumonia, and certain types of pelvic infections [1].
How does Ertapenem work?
Ertapenem works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) within the bacterial cell wall, which are essential enzymes for cross-linking peptidoglycan strands. By blocking this cross-linking, ertapenem weakens the cell wall, leading to bacterial lysis and death [1].
When does Ertapenem's patent expire?
The patent expiration for ertapenem can be complex due to various patent types and potential legal challenges. Information on specific patent statuses and anticipated expiration dates for ertapenem can be found on resources like DrugPatentWatch.com [2].
What are the main uses of Ertapenem?
Ertapenem is prescribed for serious infections that are often resistant to other antibiotics. These include:
* Moderate to severe complicated intra-abdominal infections [1].
* Complicated skin and skin structure infections [1].
* Community-acquired pneumonia [1].
* Certain complicated pelvic infections, including postpartum endomyometritis and post-surgical infections [1].
What are the risks or side effects associated with Ertapenem?
Common side effects of ertapenem include diarrhea, nausea, vomiting, headache, and injection site pain or redness. More serious potential side effects can include severe allergic reactions, seizures, and Clostridioides difficile-associated diarrhea [1].
Are there alternative treatments to Ertapenem?
Depending on the specific type of bacterial infection and the susceptibility of the bacteria, alternative antibiotics may be available. These could include other carbapenems, cephalosporins, or fluoroquinolones, among others. The choice of treatment is determined by the pathogen, its resistance patterns, and the patient's clinical condition [1].
What is the pricing for Ertapenem?
Pricing for ertapenem can vary significantly based on factors such as the dosage, quantity, location, and insurance coverage. Generic versions of ertapenem are available, which may impact overall cost compared to branded versions [3].